Sat.Aug 14, 2021 - Fri.Aug 20, 2021

article thumbnail

Google says health projects will continue even as it unwinds dedicated health division

Fierce Healthcare

Google says health projects will continue even as it unwinds dedicated health division. hlandi. Fri, 08/20/2021 - 19:08.

145
145
article thumbnail

Beckley Psytech raises $80m for psychedelic meds development

pharmaphorum

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its psilocybin-based therapies. The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Accenture survey reflects changing patient experiences

Outsourcing Pharma

The check-in with nearly 1,800 US healthcare consumers reflects how COVID-19 and other factors have impacted patient access, equity, experience and trust.

110
110
article thumbnail

SAVE THE DATE: PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 – Sep. 16th

Pharma Marketing Network

SAVE THE DATE – PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 | SEP. 16th, 12:00PM – 1:30PM EST. SAVE YOUR SEAT TODAY. Telehealth: Is It Here to Stay? Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care. Pharmaceutical brands must adapt to this new modality and pivot their promotional efforts to ensure that they can leverage the Telehealth channel effectively.

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Insurers take cue from providers, begin requiring vaccines for employees

Fierce Healthcare

Insurers take cue from providers, begin requiring vaccines for employees. pminemyer. Thu, 08/19/2021 - 12:32.

Insurance 140
article thumbnail

NICE says yes to Novartis’ Rydapt for rare blood disorder

pharmaphorum

Novartis’ Rydapt has become the first and only licensed treatment for rare and life-threatening blood disorder systemic mastocytosis (SM) to be cleared for routine NHS use, after getting a green light from NICE. The decision means around 170 people with advanced SM in England and Wales will be eligible for treatment with oral, twice-daily drug, which since 2018 has also been cleared for NHS treatment of a form of acute myeloid leukaemia.

124
124

More Trending

article thumbnail

NICE’s health technology assessment methods and processes to be evaluated

Pharma Times

Public consultation launches on proposed changes aiming to provide earlier access to new treatments

54
article thumbnail

Cerner taps Google, Geisinger vet David Feinberg as new CEO

Fierce Healthcare

Cerner taps Google, Geisinger vet David Feinberg as new CEO. hlandi. Thu, 08/19/2021 - 21:17.

Cerner 138
article thumbnail

Global regulators seek permanent working group on AI

pharmaphorum

Rapid advances in the use of artificial intelligence (AI) in healthcare and medicines development are at risk of outstripping current regulatory frameworks, according to a new report. The International Coalition of Medicines Regulatory Authorities (ICMRA) has recommended that a new permanent working group be set up to keep tabs on the use of AI and make sure that regulations can accommodate new developments.

article thumbnail

Latest COVID-19 updates from the FDA

Outsourcing Pharma

The US Food and Drug Administration continues to review potential preventatives and treatments for the virus, and to offer advice to life-sciences professionals and civilians alike.

FDA 98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

UK approves monoclonal antibody treatment for COVID-19

Pharma Times

Regeneron/Roche's drug found to reduce hospitalisation

52
article thumbnail

Biden administration to invest $19M to expand telehealth in rural, underserved areas

Fierce Healthcare

Biden administration to invest $19M to expand telehealth in rural, underserved areas. hlandi. Wed, 08/18/2021 - 08:15.

138
138
article thumbnail

Health Innovators: PureTech Health’s Daphne Zohar

pharmaphorum

In latest episode of our Health Innovators video interview series, Dr Paul Tunnah speaks to Daphne Zohar, the co-founder and CEO of PureTech Health. They discuss the publicly-listed biotech’s pipeline projects and focus on the BIG (brain-immune-gut) axis as well as PureTech’s interest in digital therapeutics. Daphne explains how she built an impressive team of board advisors for her company, plus the challenges and experience of fund raising.

article thumbnail

Secure pharma supply chain requires connections, information

Outsourcing Pharma

A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patientsâand how one solution can close the gap.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

NICE recommends Novartis’ Rydapt for AdvSM treatment

Pharma Times

Treatment provides therapeutic benefits to adults with the disease

52
article thumbnail

Maven Clinic nabs $110M funding round and a boost from Oprah to reach unicorn status

Fierce Healthcare

Maven Clinic nabs $110M funding round and a boost from Oprah to reach unicorn status. hlandi. Tue, 08/17/2021 - 12:50.

137
137
article thumbnail

Organicell on regenerative medicine: the pharmaphorum podcast

pharmaphorum

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine. They looked at the development of regenerative medicine and where Organicell hopes to add to that field. Then, with the company pivoting to try and help tackle Covid, they also discussed how that change was made possible and where Organicell’s focus will be.

111
111
article thumbnail

3D tablet printing needs the right excipient: DFE Pharma

Outsourcing Pharma

The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.

81
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

MHRA nod for Moderna’s COVID-19 vaccine for 12- to 17- year-olds

Pharma Times

UK regulator confirms vaccine is “safe and effective” in this age group

article thumbnail

Mayo posts $451M in profit in Q2 amid uneven rebound in patient volumes

Fierce Healthcare

Mayo posts $451M in profit in Q2 amid uneven rebound in patient volumes. rking. Fri, 08/20/2021 - 11:28.

136
136
article thumbnail

Does draft RCT guide set the scene for future trials?

pharmaphorum

A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based. The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make its views known. The publication, which is out for public consultation until 15 September, said RCTs played a central role in generating the evidence needed to inform the de

article thumbnail

Paige, Perspectum forge AI-centered clinical trial alliance

Outsourcing Pharma

The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.

78
article thumbnail

FDA fast tracks breast cancer candidate samuraciclib

Pharma Times

Carrick Therapeutics’ oral CDK7 inhibitor may improve patient outcomes

FDA 52
article thumbnail

Physician pay remained stagnant while productivity slumped in 2020, new survey finds

Fierce Healthcare

Physician pay remained stagnant while productivity slumped in 2020, new survey finds. agliadkovskaya. Thu, 08/19/2021 - 19:00.

136
136
article thumbnail

BMS buys into AI-designed immune drug from Exscientia

pharmaphorum

Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part of their $1.2 billion alliance. The unnamed drug candidate acts on an immunological kinase enzyme, which has proven hard to target using conventional drug discovery techniques because challenges relating to “potency, selectivity, and overall drug-like properties,” according to the partners.

article thumbnail

Orally disintegrating tablets offer range of patient benefits: Roquette

Outsourcing Pharma

A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.

64
article thumbnail

The Art of Applying to Medical School (The Pharmacy Student Edition)!

The Physician Pharmacist

Applying to medical school is no easy task, but neither is making it through pharmacy school! If you are reading this right now, then you are investigating the same calling I experienced several years ago. Every pharmacy student plays with the fantasy of going to medical school and unfortunately most will never get further than that. I am here to share my insider tips and tricks to optimize your application.

article thumbnail

KFF: Most insurers phasing out cost-sharing waivers for COVID-19 treatments

Fierce Healthcare

KFF: Most insurers phasing out cost-sharing waivers for COVID-19 treatments. rking. Thu, 08/19/2021 - 12:10.

Insurance 135
article thumbnail

MHRA clears Moderna COVID vaccine for 12 to 17 year olds

pharmaphorum

The Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and Wales in children aged 12 to 17 after getting the nod from the Medicines and healthcare products Regulatory Agency (MHRA). It joins the Pfizer/BioNTech vaccine in being an option for that age group, having been approved in Northern Ireland – which remains under the EU regulatory framework – a month ago.

article thumbnail

Trialbee partners with specialized CRO to accelerate precision medicine development

Outsourcing Pharma

The patient matching platform firm will work with Precision for Medicine on solutions to increase diversity, elevate enrollment and speed new therapies.

52
article thumbnail

EC nod for Astellas, FibroGen’s roxadustat for chronic kidney disease

Pharma Times

Phase III trial showed the drug achieved and maintained target Hb levels

49
article thumbnail

GoodRx reports spike in drug discount subscribers driving 43% revenue growth in Q2

Fierce Healthcare

GoodRx reports spike in drug discount subscribers driving 43% revenue growth in Q2. hlandi. Thu, 08/19/2021 - 12:39.

134
134
article thumbnail

Novartis says trials back Beovu safety in diabetic eye disease

pharmaphorum

There is plenty of evidence that Novartis’ ophthalmology drug Beovu can match its rivals when it comes to efficacy, with less frequent dosing, but the big question facing the company is whether it is less safe. Data from phase 3 trials of the drug in diabetic macular oedema (DMO) provide some encouragement for Novartis on the safety issue, with Beovu (brolucizumab) found to be roughly equivalent to Bayer and Regeneron’s Eylea (aflibercept) when it came to inflammatory reactions in th

98